Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 02 Dec 2021 |
2 | Reply to Exam Report (MIS-R) | 30 Dec 2021 |
3 | Authorization Letter | 03 Nov 2022 |
4 | Authorization Letter | 08 Jul 2023 |
5 | Journal Copy | 15 Nov 2023 |
6 | Certificate | 25 Jan 2024 |
1 | EXAMINATION REPORT | 12695309 | 22 Dec 2021 | |
2 | Hearing Notice (Show Cause) | 14176681 | 06 Oct 2022 | |
3 | Hearing Notice (Show Cause) | 15434442 | 15 Jun 2023 | |
4 | Tribunal Accepted Notice for : 5231325 | 15641861 | 6066398 | 19 Jul 2023 |
The application for Rizonib was made on 02 December 2021.
The trademark applicant for Rizonib is AZISTA INDUSTRIES.
Rizonib is applied in class(es) 5.
Application for Rizonib is on Registered stage.
Application Id allotted to Rizonib is 5231325.
Trademark agent or attorney for the application is R. V. R Associates.
Rizonib filed with the Intellectual property office as a WORD.